Reporting of occupational exposures to blood-borne pathogens in Australian teaching hospitals.
OBJECTIVE
To describe the reporting of occupational exposures to blood and body fluids in Australian teaching hospitals.


METHODS
Survey by questionnaire of the major teaching hospitals in Australia, December 1992.


RESULTS
Completed questionnaires were received from 88% of the 69 teaching hospitals in Australia. All responding hospital reported an established procedure for reporting and managing occupational exposures to blood and body fluids and 82% indicated willingness to contribute data to a national monitoring project. Information concerning the actual incident was recorded by all hospitals and two-thirds of hospitals had forms which specifically detailed exposures history. Patient and healthcare worker risk factors for HIV were recorded less frequently. but in 87% of hospitals blood tests were performed on both the staff member and source patient. Among 87 026 equivalent full time staff employed by the responding hospitals, 5803 injuries were reported in 1991. The median number of reported injuries as a percentage of equivalent full time staff was 7%. Estimates of non-reporting ranged from 5% to 70% (median 25%). Prophylactic zidovudine was prescribed for 50 staff from 21 hospitals in 1991.


CONCLUSIONS
All Australian teaching hospitals have an established procedure for documenting occupational exposure to blood and body fluids. Although there is limited standardisation at a national level, the information already collected and the willingness to participate indicated by a large number of teaching hospitals are sufficient for a national surveillance mechanism to be established.
MacDonald
M A
MA
National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, Sydney.
Elford
J
J
Kaldor
J M
JM
D000062:Accidents, Occupational / Q000517:prevention & control / Q000706:statistics & numerical data; D001315:Australia; D017848:Blood-Borne Pathogens; D001826:Body Fluids / Q000821:virology; D005240:Feasibility Studies; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D006784:Hospitals, Teaching; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control / Q000706:statistics & numerical data; D009313:National Health Programs; D016273:Occupational Exposure / Q000706:statistics & numerical data*; D012308:Risk Management / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine